Amphadase Related Published Studies
Well-designed clinical trials related to Amphadase (Hyaluronidase)
Adjuvant hyaluronidase to epidural steroid improves the quality of analgesia in
failed back surgery syndrome: a prospective randomized clinical trial. [2014]
Comparative pharmacokinetics and insulin action for three rapid-acting insulin
analogs injected subcutaneously with and without hyaluronidase. [2013]
Clinical trial for safety evaluation of hyaluronidase as diffusion enhancing
adjuvant for infiltration analgesia of skin with lidocaine. [2012]
Topical betamethasone and hyaluronidase in the treatment of phimosis in boys: a double-blind, randomized, placebo-controlled trial. [2011.05]
Topical betamethasone and hyaluronidase in the treatment of phimosis in boys: a
double-blind, randomized, placebo-controlled trial. [2011]
The role of adding hyaluronidase to fluoroscopically guided caudal steroid and hypertonic saline injection in patients with failed back surgery syndrome: a prospective, double-blinded, randomized study. [2010.11]
Efficacy of hydrocortisone acetate/hyaluronidase vs triamcinolone acetonide/hyaluronidase in the treatment of oral submucous fibrosis. [2010.05]
Safety and pharmacokinetics of subcutaneous ceftriaxone administered with or without recombinant human hyaluronidase (rHuPH20) versus intravenous ceftriaxone administration in adult volunteers. [2010.02]
The role of adding hyaluronidase to fluoroscopically guided caudal steroid and
hypertonic saline injection in patients with failed back surgery syndrome: a
prospective, double-blinded, randomized study. [2010]
Safety and pharmacokinetics of subcutaneous ceftriaxone administered with or
without recombinant human hyaluronidase (rHuPH20) versus intravenous ceftriaxone
administration in adult volunteers. [2010]
The INFUSE-Morphine IIB study: use of recombinant human hyaluronidase (rHuPH20) to enhance the absorption of subcutaneous morphine in healthy volunteers. [2009.11]
Accelerated pharmacokinetics and glucodynamics of prandial insulins injected with recombinant human hyaluronidase. [2009.06]
Efficacy and safety of hyaluronidase 75 IU as an adjuvant to mepivacaine for retrobulbar anesthesia in cataract surgery. [2008.11]
Predicting response of vitreous hemorrhage after intravitreous injection of highly purified ovine hyaluronidase (Vitrase) in patients with diabetes. [2008.10]
Randomized sibling-oocyte study using recombinant human hyaluronidase versus bovine-derived Sigma hyaluronidase in ICSI patients. [2008.08]
The effect of hyaluronidase on ultrasound-measured dispersal of local anaesthetic following sub-Tenon injection. [2008.08]
Use of hyaluronidase to prevent perineal trauma during spontaneous delivery: a pilot study. [2008.07]
Hyaluronidase increases the duration of mepivacaine in inferior alveolar nerve blocks. [2008.02]
Assessing the Role of Human Recombinant Hyaluronidase in Gravity-Driven Subcutaneous Hydration: The INFUSE-LR Study. [2007.12]
Hyaluronidase reduces local anaesthetic volumes for sub-Tenon's anaesthesia. [2007.11]
Use of hyaluronidase for cervical ripening: a randomized trial. [2007.01]
Well-designed clinical trials possibly related to Amphadase (Hyaluronidase)
Effect of pressure-reducing devices on the quality of anterior orbit anesthesia. [2011.06]
Levobupivacaine vs. racemic bupivacaine in peribulbar anaesthesia: a randomized double blind study in ophthalmic surgery. [2010.06]
Protocol for evaluation of the comparative effectiveness of percutaneous adhesiolysis and caudal epidural steroid injections in low back and/or lower extremity pain without post surgery syndrome or spinal stenosis. [2010.03]
Peribulbar anesthesia for cataract surgery: effect of lidocaine warming and alkalinization on injection pain, motor and sensory nerve blockade. [2010.03]
The effect on outcome of peribulbar anaesthesia in conjunction with general anesthesia for vitreoretinal surgery. [2010.03]
Continuous subcutaneous delivery of medications for home care palliative
patients-using an infusion set or a pump? [2010]
Physiotherapeutic treatment improves oral opening in oral submucous fibrosis. [2009.02]
A comparative study between 25 x 0.70 mm and 20 x 0.55 mm needles for retrobulbar block with small volume of anesthetic for the treatment of cataracts by phacoemulsification. [2008.11]
Comparison of 4% articaine and 0.5% levobupivacaine/2% lidocaine mixture for sub-Tenon's anaesthesia in phacoemulsification cataract surgery: a randomised controlled trial. [2008.04]
Preemptive sub-Tenon's anesthesia for pars plana vitrectomy under general anesthesia: is it effective? [2007.05]
Other research related to Amphadase (Hyaluronidase)
Hyaluronidase for reducing perineal trauma. [2014]
Tolerability and pharmacokinetic properties of ondansetron administered
subcutaneously with recombinant human hyaluronidase in minipigs and healthy
volunteers. [2014]
Subcutaneous administration of rituximab (MabThera) and trastuzumab (Herceptin)
using hyaluronidase. [2013]
A randomized clinical trial of recombinant human hyaluronidase-facilitated
subcutaneous versus intravenous rehydration in mild to moderately dehydrated
children in the emergency department. [2012]
Accelerating and improving the consistency of rapid-acting analog insulin
absorption and action for both subcutaneous injection and continuous subcutaneous
infusion using recombinant human hyaluronidase. [2012]
Reduction in intrasubject variability in the pharmacokinetic response to insulin after subcutaneous co-administration with recombinant human hyaluronidase in healthy volunteers. [2011.10]
Clinical Trial for Safety Evaluation of Hyaluronidase as Diffusion Enhancing Adjuvant for Infiltration Analgesia of Skin with Lidocaine. [2011.09.07]
Techniques for hyaluronidase-facilitated subcutaneous fluid administration with recombinant human hyaluronidase: the increased flow utilizing subcutaneously enabled administration technique (INFUSE AT) study. [2011.09]
Hyaluronidase behavior at the air/liquid and air/lipid interfaces and improved enzymatic activity by its immobilization in a biomembrane model. [2011.04.28]
Hyaluronidase shortens levobupivacaine lumbosacral epidural anaesthesia in dogs. [2011.04]
Accelerated insulin pharmacokinetics and improved postprandial glycemic control in patients with type 1 diabetes after coadministration of prandial insulins with hyaluronidase. [2011.03]
Inhibitory effect of a hot water extract of coffee "silverskin" on hyaluronidase. [2011]
Techniques for hyaluronidase-facilitated subcutaneous fluid administration with
recombinant human hyaluronidase: the increased flow utilizing subcutaneously
enabled administration technique (INFUSE AT) study. [2011]
Hyaluronidase modifies the biomechanical properties of the rat cervix and shortens the duration of labor independent of myometrial contractility. [2010.12]
Hyaluronidase treatment of graft pancreatitis in rats: marked effects on the blood perfusion of the transplanted pancreas. [2010.11]
Efficacy of alpha lipoic acid in adjunct with intralesional steroids and hyaluronidase in the management of oral submucous fibrosis. [2010.10]
Neuroprotective effects of immobilized granulocyte colony-stimulating factor and hyaluronidase. [2010.10]
Experience with a naphthylmedetomidine-ketamine-hyaluronidase combination in inducing immobilization in anthropoid apes. [2010.06]
The Role of Adding Hyaluronidase to Fluoroscopically Guided Caudal Steroid and Hypertonic Saline Injection in Patients with Failed Back Surgery Syndrome: A Prospective, Double-Blinded, Randomized Study. [2010.04.19]
Review of the mechanism of action and clinical efficacy of recombinant human hyaluronidase coadministration with current prandial insulin formulations. [2010.03.01]
Hyaluronidase for the management of dextrose extravasation. [2010.02]
Hyaluronidase allergy: a rare cause of periorbital inflammation. [2010.02]
Hyaluronidase: a review of approved formulations, indications and off-label use in chronic pain management. [2010.01]
Use of hyaluronidase to improve chemical immobilization of free-ranging polar bears (Ursus maritimus). [2010.01]
Reassessing the role of hyaluronidase in yellow jacket venom allergy. [2010.01]
Efficacy of hydrocortisone acetate/hyaluronidase vs triamcinolone
acetonide/hyaluronidase in the treatment of oral submucous fibrosis. [2010]
Hyaluronidase in the correction of hyaluronic acid-based fillers: a review and a recommendation for use. [2009.12]
Recombinant human hyaluronidase-enabled subcutaneous pediatric rehydration. [2009.11]
Effect of transplantation of peripheral blood mononuclears obtained using granulocytic colony-stimulating factor and hyaluronidase on regeneration of hemopoietic tissue during myelosuppression. [2009.07]
Other possibly related research studies
A complete hyaluronan hydrodynamic characterization using a size exclusion chromatography-triple detector array system during in vitro enzymatic degradation. [2010.09.01]
[Extra- and paravasation of cytotoxic drugs. Pathomechanisms and current preventive measures] [2010.03]
In vivo native fluorescence spectroscopy and nicotinamide adinine dinucleotide/flavin adenine dinucleotide reduction and oxidation states of oral submucous fibrosis for chemopreventive drug monitoring. [2010.01]
To circ or not to circ: clinical and pharmacoeconomic outcomes of a prospective trial of topical steroid versus primary circumcision. [2010.01]
Role of urinary biomarkers of N,N-dimethylformamide in the early detection of hepatic injury among occupational exposed workers. [2010.04]
Amorphous basophilic deposit in the superficial dermis of the lip in an 80 year old. [2010.05]
Modulation of hyaluronan fragmentation by interleukin-1 beta in synovial membrane cells. [2010.04]
Acid-base balance and ventilation during sternal and lateral recumbency in field immobilized black rhinoceros (Diceros bicornis) receiving oxygen insufflation: a preliminary report. [2010.01]
Dissolving collagen fillers: enzymatic degradation of some problematic filler circumstances may now include collagens. [2009.12]
Synthesis and characterization of hyaluronic acid-poly(ethylene glycol) hydrogels via Michael addition: An injectable biomaterial for cartilage repair. [2010.06]
[Medicinal leeches] [2009.09]
Rapid vascular glucose uptake via enzyme-assisted subcutaneous infusion: enzyme-assisted subcutaneous infusion access study. [2009.11]
Treatment of injectable soft tissue filler complications. [2009.10]
The risk of alar necrosis associated with dermal filler injection. [2009.10]
In vivo autofluorescence characteristics of pre- and post-treated oral submucous fibrosis: a pilot study. [2009.07]
Subcutaneous immunoglobulin: opportunities and outlook. [2009.12]
Anti-necrosis potential of polyphenols against snake venoms. [2009]
Continuous subcutaneous delivery of medications for home care palliative patients-using an infusion set or a pump? [2010.09]
Comparing the effect of using atracourium and cis-atracourium as adjuvant agents to the local anesthetic substance on peribulbar-induced akinesia. [2011.08]
Short term pharmacological immobilization in macaque monkeys. [2011.09]
Fragmented hyaluronan is an autocrine chemokinetic motility factor supported by the HAS2-HYAL2/CD44 system on the plasma membrane. [2011.11]
Little evidence that current interventions can benefit patients with OSMF. [2011]
[Introduction of a clinical protocol for extravasation at the National Institute of Oncology, Budapest, Hungary]. [2011.03]
[Extravasation of cytostatic drugs]. [2011.03]
Role of hyaluronan and hyaluronan-binding proteins in lung pathobiology. [2011.08]
Two-quadrant high-volume sub-Tenon's anaesthesia for vitrectomy: a randomised controlled trial. [2011.05.05]
A link between smooth muscle cell death and extracellular matrix degradation during vascular atrophy. [2011.07]
Adjuvants to local anaesthesia in ophthalmic surgery. [2011.10]
Facile synthesis and characterization of disulfide-cross-linked hyaluronic acid hydrogels for protein delivery and cell encapsulation. [2011.04.11]
Subcutaneous rehydration: updating a traditional technique. [2011.03]
Clinical experience with hyaluronic acid-filler complications. [2011.07]
Delayed hypersensitivity reaction to Restylane (R) SubQ. [2011.01]
Two cases of drug-induced orbital inflammatory disease. [2011.01]
Passive immune-prophylaxis against influenza virus infection by the expression of neutralizing anti-hemagglutinin monoclonal antibodies from plasmids. [2011]
Extravasation management: clinical update. [2011.02]
A technique for filling the temples with highly diluted hyaluronic acid: the "dilution solution". [2011.01]
The venom composition of the parasitic wasp Chelonus inanitus resolved by combined expressed sequence tags analysis and proteomic approach. [2010.12.07]
Study of the efficiency of chemically assisted enucleation method for handmade cloning in goat (Capra hircus). [2011.08]
Cross reactivity between European hornet and yellow jacket venoms. [2010.08]
Hyaluronan oligosaccharides promote functional recovery after spinal cord injury in rats. [2011.01.25]
The effectiveness of endoscopic epidurolysis in treatment of degenerative chronic low back pain: a prospective analysis and follow-up at 48 months. [2011]
|